These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8697971

  • 21. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
    Phillips RM, Burger AM, Loadman PM, Jarrett CM, Swaine DJ, Fiebig HH.
    Cancer Res; 2000 Nov 15; 60(22):6384-90. PubMed ID: 11103802
    [Abstract] [Full Text] [Related]

  • 22. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J, Oleschuk CJ, Guziec F, Guziec L, Fiterman DJ, Monterrosa C, Begleiter A.
    Cancer Chemother Pharmacol; 2002 Feb 15; 49(2):101-10. PubMed ID: 11862423
    [Abstract] [Full Text] [Related]

  • 23. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
    Lee JH, Naito M, Tsuruo T.
    Cancer Res; 1994 May 01; 54(9):2398-403. PubMed ID: 8162587
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Immortalisation of a human diploid fibroblast cell strain: a DT-diaphorase paradox.
    Kuehl BL, Brezden CB, Traver RD, Siegel D, Ross D, Renzing J, Rauth AM.
    Br J Cancer Suppl; 1996 Jul 01; 27():S19-22. PubMed ID: 8763839
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line.
    Xia H, Bleicher RJ, Gupta V, Zaren HA, Singh SV.
    Int J Cancer; 1997 Mar 04; 70(5):606-11. PubMed ID: 9052763
    [Abstract] [Full Text] [Related]

  • 28. Role of GRP58 in mitomycin C-induced DNA cross-linking.
    Celli CM, Jaiswal AK.
    Cancer Res; 2003 Sep 15; 63(18):6016-25. PubMed ID: 14522930
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors.
    Li D, Gan Y, Wientjes MG, Badalament RA, Au JL.
    J Urol; 2001 Dec 15; 166(6):2500-5. PubMed ID: 11696818
    [Abstract] [Full Text] [Related]

  • 32. Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin c in small cell lung cancer cells.
    Lee CS, Park SY, Ko HH, Han ES.
    Biochem Pharmacol; 2004 Nov 01; 68(9):1857-67. PubMed ID: 15450951
    [Abstract] [Full Text] [Related]

  • 33. DNA interstrand cross-link and free radical formation in a human multidrug-resistant cell line from mitomycin C and its analogues.
    Dusre L, Rajagopalan S, Eliot HM, Covey JM, Sinha BK.
    Cancer Res; 1990 Feb 01; 50(3):648-52. PubMed ID: 2153443
    [Abstract] [Full Text] [Related]

  • 34. Engagement of integrinβ1 induces resistance of bladder cancer cells to mitomycin-C.
    Zhang CJ, Shen ZJ, Pan CW, Zhong S, Li T, Zhang MG.
    Urology; 2012 Mar 01; 79(3):638-43. PubMed ID: 22386417
    [Abstract] [Full Text] [Related]

  • 35. Molecular targeting of mitomycin C chemotherapy.
    Nishiyama M, Suzuki K, Kumazaki T, Yamamoto W, Toge T, Okamura T, Kurisu K.
    Int J Cancer; 1997 Aug 07; 72(4):649-56. PubMed ID: 9259406
    [Abstract] [Full Text] [Related]

  • 36. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Xu BH, Jani JP, Emerson EO, Backes MG, Rihn C, Scalamogna D, Stemmler N, Specht S, Blanock K.
    Int J Cancer; 1995 May 04; 61(3):431-6. PubMed ID: 7729958
    [Abstract] [Full Text] [Related]

  • 37. Knockdown of IGF-IR by Antisense Oligodeoxynucleotide auguments the sensitivity of bladder cancer cells to mitomycin.
    Sun HZ, Wu SF, Tu ZH.
    Acta Pharmacol Sin; 2001 Sep 04; 22(9):841-6. PubMed ID: 11749868
    [Abstract] [Full Text] [Related]

  • 38. Reductive activation of mitomycin C by thiols: kinetics, mechanism, and biological implications.
    Paz MM.
    Chem Res Toxicol; 2009 Oct 04; 22(10):1663-8. PubMed ID: 19791750
    [Abstract] [Full Text] [Related]

  • 39. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH, Naito M, Nakajima M, Tsuruo T.
    Cancer Chemother Pharmacol; 1993 Oct 04; 33(3):215-20. PubMed ID: 7505723
    [Abstract] [Full Text] [Related]

  • 40. Non-enzymatic and enzymatic activation of mitomycin C: identification of a unique cytosolic activity.
    Joseph P, Xu Y, Jaiswal AK.
    Int J Cancer; 1996 Jan 17; 65(2):263-71. PubMed ID: 8567127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.